Modulation of endogenous gene expression in cells

Details Modulation of endogenous gene expression in cells Modulation of endogenous gene expression in cells

2005-08-23

2005-08-23

Brusca, John S. (Department: 1631)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S320100, C435S069100, C435S455000, C435S458000, C536S023400

Reexamination Certificate

active

06933113

ABSTRACT:
Disclosed herein are methods and compositions for modulating expression of endogenous cellular genes using recombinant zinc finger proteins.

REFERENCES:
patent: 4990607 (1991-02-01), Katagiri et al.
patent: 5096814 (1992-03-01), Aivasidis et al.
patent: 5096815 (1992-03-01), Ladner et al.
patent: 5198346 (1993-03-01), Ladner et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5243041 (1993-09-01), Fernandez-Pol
patent: 5302519 (1994-04-01), Blackwood et al.
patent: 5324638 (1994-06-01), Tao et al.
patent: 5324818 (1994-06-01), Nabel et al.
patent: 5324819 (1994-06-01), Oppermann et al.
patent: 5340739 (1994-08-01), Stevens et al.
patent: 5348864 (1994-09-01), Barbacid et al.
patent: 5350840 (1994-09-01), Call et al.
patent: 5356802 (1994-10-01), Chandrasegaran
patent: 5376530 (1994-12-01), De The et al.
patent: 5403484 (1995-04-01), Ladner et al.
patent: 5436150 (1995-07-01), Chandrasegaran
patent: 5487994 (1996-01-01), Chandrasegaran
patent: 5498530 (1996-03-01), Schatz et al.
patent: 5578483 (1996-11-01), Evans et al.
patent: 5597693 (1997-01-01), Evans et al.
patent: 5602009 (1997-02-01), Evans et al.
patent: 5639592 (1997-06-01), Evans et al.
patent: 5674738 (1997-10-01), Abramson et al.
patent: 5702914 (1997-12-01), Evans et al.
patent: 5789538 (1998-08-01), Rebar et al.
patent: 5792640 (1998-08-01), Chandrasegaran
patent: 5814618 (1998-09-01), Bujard et al.
patent: 5830721 (1998-11-01), Stemmer et al.
patent: 5869618 (1999-02-01), Lippman et al.
patent: 5871902 (1999-02-01), Weininger et al.
patent: 5871907 (1999-02-01), Winter et al.
patent: 5916794 (1999-06-01), Chandrasegaran
patent: 5939538 (1999-08-01), Leavitt et al.
patent: 5972615 (1999-10-01), An et al.
patent: 6001885 (1999-12-01), Vega et al.
patent: 6004941 (1999-12-01), Bujard et al.
patent: 6007988 (1999-12-01), Choo et al.
patent: 6013453 (2000-01-01), Choo et al.
patent: 6140081 (2000-10-01), Barbas
patent: 6140466 (2000-10-01), Barbas, III et al.
patent: 6160091 (2000-12-01), Peukert et al.
patent: 6242568 (2001-06-01), Barbas, III et al.
patent: 6270990 (2001-08-01), Anderson et al.
patent: 0 875 567 (1998-04-01), None
patent: WO 92/02536 (1992-02-01), None
patent: WO 95/11922 (1995-05-01), None
patent: WO 95/19431 (1995-07-01), None
patent: WO 96/06110 (1996-02-01), None
patent: WO 96/06166 (1996-02-01), None
patent: WO 96/11267 (1996-04-01), None
patent: WO 96/20951 (1996-07-01), None
patent: WO 96/32475 (1996-10-01), None
patent: WO 97/27212 (1997-07-01), None
patent: WO 97/27213 (1997-07-01), None
patent: WO 98/53057 (1998-11-01), None
patent: WO 98/53058 (1998-11-01), None
patent: WO 98/53059 (1998-11-01), None
patent: WO 98/53060 (1998-11-01), None
patent: WO 98/54311 (1998-12-01), None
patent: WO 99/27092 (1999-06-01), None
patent: WO 99/36553 (1999-07-01), None
patent: WO 99/41371 (1999-08-01), None
patent: WO 99/42474 (1999-08-01), None
patent: WO 99/45132 (1999-09-01), None
patent: WO 99/47656 (1999-09-01), None
patent: WO 99/48909 (1999-09-01), None
patent: WO 00/23464 (2000-04-01), None
patent: WO 00/27878 (2000-05-01), None
patent: WO 00/41566 (2000-07-01), None
patent: WO 00/42219 (2000-07-01), None
patent: WO 01/04296 (2001-01-01), None
patent: WO 02/066640 (2002-08-01), None
patent: WO 03/016496 (2003-02-01), None
Altincicek et al. “Interaction of the corepressor alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal . . . ” J. Biol. Chem. 275:7662-7667 (2000).
Cook et al. “Three conserved transcriptional repressor domains are a defining feature of the TIEG subfamily . . . ” J. Biol. Chem. 274:29500-29504 (1999).
Crawford et al. “Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR . . . ” Mol. Cell. Biol. 18:2949-2956 (1998).
Ito et al. “DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain . . . ” Mol. Cell. Biol. 17:1476-1483 (1997).
Lai et al. “RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of . . . ” Mol. Cell. Biol. 21:2918-2932 (2001).
LaPierre et al. “Identification of a novel transcriptional repressor encoded by human cytomegalovirus” J. Virology 75:6062-6069 (2001).
Maxon et al. “Ash1p is a site-specific DNA-binding protein that actively represses transcription” Proc. Natl. Acad. Sci. USA 98:1495-1500 (2001).
Sabbattini et al. “Binding of lkaros to the lambda5 promoter silences transcription . . . ” EMBO Journal 20:2812-2822 (2001).
Zazopoulos et al. “DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis” Nature 390:311-315 (1997).
Zhang et al. “A conserved alpha-helical motif mediates teh interaction of Sp1-like transcriptional repressore . . . ” Mol. Cell. Biol. 21:5041-5049 (2001).
Agarwal et al., “Stimulation of Transcript Elongation Requires Both the Zinc Finger and RNA Polymerase II Binding Domains of Human TFIIS,”Biochemistry 30(31):7842-7851 (1991).
Antao et al., “A Thermodynamic Study of Unusually Stable RNA and DNA Hairpins,”Nuc. Acids. Res. 19(21):5901-5905 (1991).
Barbas, C. F., “Recent Advances in Phage Display,”Curr. Opin. Biotech. 4:526-530 (1993).
Barbas et al., “Assembly of Combinatorial Antibody Libraries on Phage Surfaces: The Gene III Site,”PNAS 88:7978-7982 (1991).
Barbas et al., “Semisynthetic Combinatorial Antibody Libraries: A Chemical Solution to the Diversity Problem,”PNAS 89:4457-4461 (1992).
Beerli et al., “Toward Controlling Gene Expression at Will: Specific Regulation of the erbB-2/HER-2 Promoter by Using Polydactyl Zinc Finger Proteins Constructed From Modular Building Blocks,”Proc. Natl. Acad. Sci. U.S.A. 95:14628-14633 (1998).
Beerli et al., “Positive and negative regulation of endogenous genes by designed transcription factors,”Proc. Natl. Acad. Sci. U.S.A. 97:1495-1500 (2000).
Bellefroid et al., “Clustered Organization of Homologous KRAB Zinc-Finger Genes With Enhanced Expression in Human T Lymphoid Cells,”EMBO J. 12(4):1363-1374 (1993).
Berg, J.M., “DNA Binding Specificity of Steroid Receptors,”Cell 57:1065-1068 (1989).
Berg, J.M., “Sp1 and the Subfamily of Zinc-Finger Proteins with Guanine-Rich Binding Sites,”PNAS 89:11109-11110 (1992).
Berg et al., “The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc,”Science 271:1081-1085 (1996).
Berg, J.M., “Letting Your Fingers do the Walking,”Nature Biotechnology 15:323 (1997).
Bergqvist et al., “Loss of DNA-binding and new Transcriptional Trans-Activation Function in Polyomavirus Large T-Angtigen with Mutation of Zinc Finger Motif,”Nuc. Acids Res. 18(9):2715-2720 (1990).
Blaese et al., “Vectors in Cancer Therapy: How Will They Deliver?,”Cancer Gene Therapy 2(4):291-297 (1995).
Bonde et al., “Ontogeny of the v-erbA Oncoprotein from the Thyroid Hormone Receptor: An Alteration in the DNA Binding Domain Plays a Role Crucial for verbA Function,”J. Virology 65(4):2037-2046 (1991).
Caponigro et al., “Transdominant Genetic Analysis of a Growth Control Pathway,” PNAS 95:7508-7513 (1998).
Celenza et al., “A Yeast Gene That Is Essential for Release from Glucose Repression Encodes a Protein Kinase,”Science 233:1175-1180 (1986).
Cheng et al., “Identification of Potential Target Genes for Adrlp through Characterization of Essential Nucleotides in UASI,”J. Mol. Cellular Biol. 14(6):3842-3852 (1994).
Cheng et al., “A Single Amino Acid Substitution in Zinc Finger 2 of Adrlp Changes its Binding Specificity at two Positions in UAS1,”.J. Mol. Biol. 251:1-8 (1995).
Choo et al., A Role in DNA-Binding for the Linker Sequences of the First Three Zinc Fingers of TFIIIANuc. Acids Res. 21(15):3341-3346 (1993).
Choo et al., “Promoter-Specific Activation of Gene Expression Directed By Bacteriophage-Selected Zinc Fingers,”J. Mol. Biol. 273:525-532 (1997).
Choo et al., “Designing DNA-Binding P

Affiliated with

Also associated with

Rating

Modulation of endogenous gene expression in cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulation of endogenous gene expression in cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of endogenous gene expression in cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3519151